This message was sent to ##Email##
|
|
|
|
|
|
Advertisement
|
|
|
Cancer Therapy Advisor
Additional study is warranted to identify the pathophysiologic mechanisms behind the link between preoperative and postoperative hyponatremia and perioperative morbidity in patients with head and neck squamous cell carcinoma, according to an article published online ahead of print in Head & Neck.
READ MORE
Advertisement
ACS
On Nov. 14, the National Accreditation Program for Breast Centers (NAPBC) will hold the Pursuing Excellence through NAPBC Accreditation workshop in Chicago at the American College of Surgeons' Headquarters. If you are applying for NAPBC accreditation or preparing for an initial or re-accreditation survey, this program is a must-attend. The National Cancer Registrars Association Program Recognition Committee has determined the Pursuing Excellence through NAPBC Accreditation program supports six CE hours. Contact the NAPBC for additional information.
READ MORE
University of Florida via Medical Xpress
One form of pancreatic cancer has a new enemy: a two-drug combination discovered by UF Health researchers that inhibits tumors and kills cancer cells in mouse models. For the first time, researchers have shown that a certain protein becomes overabundant in pancreatic neuroendocrine tumors, allowing them to thrive. They also found that pairing a synthetic compound with an existing drug provides a more effective anticancer punch than a single drug.
READ MORE
|
Promoted by
|
|
|
|
 |
ACS
On Monday, Sept. 28, the American Cancer Society (ACS) in collaboration with the National Accreditation Program for Breast Centers (NAPBC) will host Genetic Testing 101: Identifying High Risk Individuals. This live 60-minute webinar will start at 12 p.m. EST. In order to participate in this webinar, you will need to register.
READ MORE
Oncology Nurse Advisor
A high risk for venous thromboembolism following surgery for long-bone reconstruction was found in patients with metastatic cancer.
These findings from a study by Sidney Kimmel Medical College at Thomas Jefferson University researchers were published in Journal of Bone and Joint Surgery.
The researchers retrospectively reviewed 336 cases in which patients underwent intramedullary nailing for metastatic bone lesions.
READ MORE
Johns Hopkins University School of Medicine via Medical Xpress
Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest "premalignant" genetic changes that mark the potential onset of the most common and deadliest form of disease.
READ MORE
ACS
Register to attend the ACS Clinical Congress in Chicago, Oct. 4-8, and you can preorder the Webcasts today. This year's Clinical Congress includes more than 15 panel sessions in the Surgical Oncology Track that cover a variety of topics. For detailed information, please visit the Clinical Congress 2015 Web page.
Note: Webcasts will be made available after Nov. 15. Purchase provides access to the 2015 Webcast sessions and expires Dec. 31, 2016.
READ MORE
 |
|
CHAMPS Oncology’s new web-based system transforms cancer data into actionable information for strategic planning, operational and financial decisions.
• CHAMPS Seeks i2o™ Early Adopters
• i2o™ Provides Answers to Cancer Service Lines’ Questions
• Access 75+ Cancer Data Reports (Migration, Utilization & More)
|
|
Oncology Nurse Advisor
Eight of 14 patients in the first clinical trial of personalized cellular therapy for chronic lymphocytic leukemia responded to the therapy, with some complete remissions continuing beyond 4 1/2 years. These results, published in Science Translational Medicine, represent the most mature data from clinical trials of an approach known as CTL019.
The trial was conducted at the University of Pennsylvania in Philadelphia. A team from Penn's Abramson Cancer Center and the Perelman School of Medicine developed the CTL019 approach.
READ MORE
| NAPBC and CoC provide online poster to observe Breast Cancer Awareness Month
|
    |
ACS
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage your program to promote the event and use it as an opportunity to display/promote your accreditation status. To help you publicize this event within your program and the community, the NAPBC and the CoC have created a poster that you can download and print. Programs that are solely CoC accredited or accredited by both the CoC and NAPBC can access the poster by logging into CoC Datalinks and clicking on Marketing Resources Staff and NAPBC-accredited breast centers can log into the NAPBC portal and click on the "2015 Breast Cancer Awareness Month Poster" link in the "View Downloadable Center Resources" section to access the marketing resources Web page. For more information, contact srubin@facs.org.
|
Promoted by
|
|
|
|
 |
Cancer Research UK
More than half of people invited to take a new bowel cancer screening test didn't take up the opportunity — even though it could stop them developing or dying from the disease, according to a Cancer Research UK report published recently in the Journal of Medical Screening. Cancer Research UK scientists found that people from poorer neighbourhoods were less likely to take up screening, with only one third in the most deprived neighbourhood going for their appointment compared to over half in the most affluent.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
